What is translational medicine?

Translational medicine can be defined as the continuum from a scientific idea or finding to a diagnostic tool and/or therapy applied to human diseases. The field of translational medicine encompasses molecular medicine, intellectual property, financing, regulation, preclinical and clinical trial studies, among other disciplines. Translational Medicine has emerged as a discipline central to the goal of converting basic science discoveries to diagnostic and therapeutic tools that can be harnessed to treat disease and improve human health.


The Mission Of The Eureka Institute

Our mission is to develop a community of translational medicine professionals equipped to inspire and catalyze the application of discoveries for the benefit of human health. We do this through:

Who Are We?

The EUREKA Institute for Translational Medicine (referred henceforth as the EUREKA; www.eurekainstitute.org), was established in 2008 by leaders in the field and incorporated as a not-for-profit organization. The birth of Eureka arises from the realization that the itinerary from molecular to clinical medicine requires a seamless trajectory to insure that talent, ideas, and potential cures are captured.

An important resource and one that is fundamental unmet need is human capital: a person who is a builder of bridges, who has the knowledge, the skill and the desire to navigate the challenges and components of this complex field. System-wide networks which can inspire, catalyze and sustain Translational Medicine on an international scale simply do not exist. These unmet needs are perceived as the main hurdle to the integration between Molecular and Clinical Medicine into a seamless gradient leading to a patient-centered approach to healing (Precision Medicine).

Eureka aims to develop a Network of multidisciplinary translational professionals who create a global community of Translational Medicine professionals to advance the application of biomedical innovation for the tangible benefit of patients and society as a whole.  In its first 8 successful years, Eureka has defined its mission by focusing on educational activities, most prominently the Certificate Course – as of May 2015, 240 investigators from Canada, USA, Europe, South America, Africa, Asia and Australia have completed the certificate course, and more recently, the development of e-learning modules.

Eureka is now entering its next phase, where its objectives will be:

  • To create a network of alumni, faculty and partners, capable of expanding the teaching and practice of translational medicine beyond the annual Certificate Course to regional hubs;

  • To initiate collaborative translational research programs that address unmet patient needs. To accomplish this, Eureka will leverage its members and coalesce their immense potential into a shared Eurekian vision. This Eureka International Network will engage in relational, operational, and educational activities.

Our Network